Sustainability & Climate

Spin Master's interactive T. rex wins Toy of the Year, while the industry raises over $1M for charity and honors new Hall of Fame legends at the 2026 TOTY Awards.

Dowinx is pushing user-driven design and certified tech in its gaming chairs. But do these promises hold up under the pressure of long-term use?

A West Virginia jury awarded millions to Pardee's subsidiary after a utility's power lines blocked access to coal, but a lengthy legal appeal looms.

Pharmaceutical giant Cencora locks in $3B in financing to pay down debt from its massive OneOncology acquisition, deepening its strategic bet on cancer care.

Honeywell's $1.19 quarterly dividend highlights its robust financial health and commitment to shareholders, backed by a strong forecast for 2026.

A new report reveals a nearly 6% drop in US beer shipments for 2025, signaling a major shift as consumers turn to spirits, cannabis, and NA options.

A new $500M fund aims to profit from the U.S. housing shortage by banking on its scarcest resource: land. But can it deliver for investors and builders?

As devastating wildfires become more common, toxic smoke is seeping indoors. Learn about the hidden health risks and the technology that can keep you safe.

With up to 90% discounts, OFF BEAUTY is challenging Olive Young's dominance and reshaping how Koreans and tourists shop for K-beauty. Is it sustainable?

Illinois Tool Works reaffirms its 'Dividend King' status with a new payout, signaling robust financial health and confidence in the industrial sector's recovery.

As its National Wine Day turns 25, see how Moldova turned post-Soviet crisis into an award-winning wine powerhouse and a top tourism destination.

Emmy-winner Brandon McMillan will unveil a revolutionary new line of dog training tools at the pet industry's premier event. What does he have in store?

A world-first quantum teleportation over commercial fiber proves a secure, unhackable internet is closer than ever, thanks to a Canadian tech partnership.

Iconic haircare brand John Frieda unveils a major rebrand with new formulas, a social-first campaign, and the influential Nader Sisters at the helm.

Nemours Foundation adds Advocate Health's Dr. Betty Chu to its board, a strategic move to leverage her expertise in quality, equity, and large-scale operations.

The biohacking boom gets a new tool as QuasarMD expands from facial devices to full-body recovery, targeting a market projected to exceed $100 billion.

A new "smart bomb" cancer drug, PB-223, shows complete tumor eradication with minimal toxicity in preclinical studies, setting the stage for a new battle.

The biotech firm enacts a 1-for-25 stock split to avoid delisting, placing its promising cancer therapy pipeline under a brighter, more critical spotlight.

A new book reveals why physician marriages are surprisingly stable and what every dual-career couple can learn from their success in balancing love and life.

With a $15 million funding boost, Nasus Pharma is accelerating its powder-based intranasal epinephrine, NS002, challenging the EpiPen's dominance.